Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report.

Wendy Shelley, A A Starreveld, M.E. Kirk, +6

Journal of Clinical Oncology

National Cancer InstituteRandomized Clinical TrialRadiologyEligible PatientsRadiation Therapy +13

Vulvodynia and psychological distress

Donna E. Stewart, A E Reicher, A. Gerulath, +1

International Journal of Gynecology & Obstetrics

External beam pelvic radiotherapy plus intraperitoneal radioactive chronic phosphate in early stage ovarian cancer: A toxic combination

A A Starreveld, Wendy Shelly, Anthony B. Miller, +3

International Journal of Radiation Oncology*Biology*Physics

Radiation TherapyMedicineGynecologyToxic CombinationClinical Radiation Oncology +5

Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium

Rabindra Roy, A. Gerulath, Anthony Cecutti, +1

Molecular and Cellular Endocrinology

MedicineUterine ReceptivityNormal EndometriumPathologyGynecology +4

High-Dose Methotrexate for Gestational Trophoblastic Disease

L. Elit, Allan Covens, Raymond Osborne, +4

Gynecologic Oncology

Maternal ImmunizationHematologyPathologyMaternal HealthHigh-dose Methotrexate +2

Gestational trophoblastic disease.

A. Gerulath, Thomas Ehlen, Paul L. Bessette, +2

PubMed

The effects of treatments with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide in darkness and in light on survival and progression in Chinese hamster ovary cells in vitro.

A. Gerulath, S. C. Barranco, Ronald M. Humphrey

PubMed

OptogeneticsLight Delayed CellsMedicineCellular PharmacologyPharmacotherapy +9

Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.

Andrea Miller, D. A. Boyes, D. Dodds, +5

PubMed

OncologyAdvanced Ovarian CancerGood PrognosisMedicineSequential Chemotherapy +11

Endometrial transcripts of human insulin-like growth factors arise by differential promoter usage

Rabindra Roy, Anthony Cecutti, A. Gerulath, +2

Molecular and Cellular Endocrinology

Developmental BiologyGrowth HormoneDifferential Promoter UsageMedicineUterine Receptivity +7

Preliminary report of a clinical trial of the treatment of patients with advanced stage III and IV ovarian cancer with melphalan, 5-fluorouracil, and methotrexate in combination and sequentially: a study of the Clinical Trials Group of the National Cancer Institute of Canada.

Klaassen Dj, Boyes Da, A. Gerulath, +3

Munich Personal RePEc Archive (Ludwig Maximilian University of Munich)

National Cancer InstituteOncologyMedicinePreliminary ReportClinical Trials +8